Inhibitor Therapeutics (INTI) Total Non-Current Liabilities (2012)
Inhibitor Therapeutics' Total Non-Current Liabilities came in at $559,953 for Q4 2012.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Total Non-Current Liabilities (2012) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.23 Bn | 1,139.82 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 648.76 Bn | 568.62 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 503.78 Bn | 476.89 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 366.20 Bn | 320.58 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 303.55 Bn | 267.54 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 269.42 Bn | 243.11 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 195.01 Bn | 169.21 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 172.42 Bn | 119.07 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Inhibitor Therapeutics | 19.12 Mn | 11.93 Mn | - | - |
API Access
Inhibitor Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();